{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:19:42Z","timestamp":1787879982945,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00728-z","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:05:12Z","timestamp":1787879112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel case of cytoplasmic CD3 positive, surface CD4 positive high-grade B-cell lymphoma with MYC rearrangement"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2157-4049","authenticated-orcid":false,"given":"Vladimir","family":"Miltchev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-6121","authenticated-orcid":false,"given":"Natalia","family":"Golardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"728_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. (2008) WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th ed. International agency for research on cancer."},{"issue":"20","key":"728_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"issue":"7","key":"728_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"issue":"8","key":"728_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/17474086.2018.1494567","volume":"11","author":"S Li","year":"2018","unstructured":"Li S, Lin P, Medeiros LJ (2018) Advances in pathological understanding of high-grade B cell lymphomas. Expert Rev Hematol 11(8):637\u2013648. https:\/\/doi.org\/10.1080\/17474086.2018.1494567","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"728_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41375-022-01778-9","volume":"37","author":"S Li","year":"2023","unstructured":"Li S, Qiu L, Xu J et al (2023) High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL\/HGBL-DH than DLBCL. Leukemia 37(2):422\u2013432. https:\/\/doi.org\/10.1038\/s41375-022-01778-9","journal-title":"Leukemia"},{"issue":"1","key":"728_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1309\/AJCP93LJPTRQPDKR","volume":"134","author":"K Kelemen","year":"2010","unstructured":"Kelemen K, Braziel RM, Gatter K, Bakke TC, Olson S, Fan G (2010) Immunophenotypic variations of Burkitt lymphoma. Am J Clin Pathol 134(1):127\u201338. https:\/\/doi.org\/10.1309\/AJCP93LJPTRQPDKR","journal-title":"Am J Clin Pathol"},{"issue":"20","key":"728_CR7","doi-asserted-by":"publisher","first-page":"33487","DOI":"10.18632\/oncotarget.16532","volume":"8","author":"N Tsuyama","year":"2017","unstructured":"Tsuyama N, Ennishi D, Yokoyama M et al (2017) Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas. Oncotarget 8(20):33487\u201333500. https:\/\/doi.org\/10.18632\/oncotarget.16532","journal-title":"Oncotarget"},{"issue":"suppl_1","key":"728_CR8","doi-asserted-by":"publisher","first-page":"A163","DOI":"10.1093\/ajcp\/138.suppl1.149","volume":"138","author":"N Golardi","year":"2012","unstructured":"Golardi N, Reichard K (2012) Burkitt lymphoma with aberrant expression of T-cell associated antigens: a rare entity in the literature. Am J Clin Pathol 138(suppl_1):A163\u2013A163. https:\/\/doi.org\/10.1093\/ajcp\/138.suppl1.149","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"728_CR9","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/PAS.0b013e31825e63a9","volume":"36","author":"JL Oliveira","year":"2012","unstructured":"Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL (2012) Clinicopathologic features of B-cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol 36(9):1364\u20131370. https:\/\/doi.org\/10.1097\/PAS.0b013e31825e63a9","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"728_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/PAS.0b013e318185d231","volume":"33","author":"J Wang","year":"2009","unstructured":"Wang J, Chen C, Lau S et al (2009) CD3-positive large B-cell lymphoma. Am J Surg Pathol 33(4):505\u2013512. https:\/\/doi.org\/10.1097\/PAS.0b013e318185d231","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"728_CR11","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1080\/10428194.2021.1953010","volume":"62","author":"U Durani","year":"2021","unstructured":"Durani U, Ansell SM (2021) CD5+ diffuse large B-cell lymphoma: a narrative review. Leuk Lymphoma 62(13):3078\u20133086. https:\/\/doi.org\/10.1080\/10428194.2021.1953010","journal-title":"Leuk Lymphoma"},{"key":"728_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116441","volume":"227","author":"D Liu","year":"2024","unstructured":"Liu D, Hu X, Chen Z, Wei W, Wu Y (2024) Key links in the physiological regulation of the immune system and disease induction: T cell receptor -CD3 complex. Biochem Pharmacol 227. https:\/\/doi.org\/10.1016\/j.bcp.2024.116441","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"728_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1182\/blood.V71.3.603.603","volume":"71","author":"JJ van Dongen","year":"1988","unstructured":"van Dongen JJ, Krissansen GW, Wolvers-Tettero IL et al (1988) Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies. Blood 71(3):603\u2013612","journal-title":"Blood"},{"issue":"2","key":"728_CR14","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1016\/s2352-3026(24)00351-x","volume":"12","author":"V Ribrag","year":"2025","unstructured":"Ribrag V, Bron D, Rymkiewicz G et al (2025) Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet. Lancet Haematol 12(2):e138\u2013e150. https:\/\/doi.org\/10.1016\/s2352-3026(24)00351-x","journal-title":"Lancet Haematol"},{"issue":"9","key":"728_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70207","volume":"9","author":"C Thieblemont","year":"2025","unstructured":"Thieblemont C, Gomes Da Silva M, Lepp\u00e4 S et al (2025) Large B-cell lymphoma (LBCL): EHA clinical practice guidelines for diagnosis, treatment, and follow-up. Hemasphere 9(9). https:\/\/doi.org\/10.1002\/hem3.70207","journal-title":"Hemasphere"},{"issue":"21","key":"728_CR16","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1182\/bloodadvances.2025016651","volume":"9","author":"B Collinge","year":"2025","unstructured":"Collinge B, Hilton LK, Wong J et al (2025) High-grade B-cell lymphoma, not otherwise specified: an LLMPP study. Blood Adv 9(21):5409\u20135422. https:\/\/doi.org\/10.1182\/bloodadvances.2025016651","journal-title":"Blood Adv"},{"issue":"9","key":"728_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1182\/blood.2020008374","volume":"140","author":"AJ Olszewski","year":"2022","unstructured":"Olszewski AJ, Kurt H, Evens AM (2022) Defining and treating high-grade B-cell lymphoma, NOS. Blood 140(9):943\u2013954. https:\/\/doi.org\/10.1182\/blood.2020008374","journal-title":"Blood"},{"issue":"12","key":"728_CR18","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3324\/haematol.2019.238162","volume":"105","author":"MED Chamuleau","year":"2020","unstructured":"Chamuleau MED, Burggraaff CN, Nijland M et al (2020) Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial. Haematologica 105(12):2805\u20132812. https:\/\/doi.org\/10.3324\/haematol.2019.238162","journal-title":"Haematologica"},{"issue":"6","key":"728_CR19","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/cncr.26433","volume":"118","author":"P Lin","year":"2012","unstructured":"Lin P, Dickason TJ, Fayad LE et al (2012) Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Cancer 118(6):1566\u20131573. https:\/\/doi.org\/10.1002\/cncr.26433","journal-title":"Cancer"},{"issue":"7","key":"728_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/01.MP.0000019577.73786.64","volume":"15","author":"N Nakamura","year":"2002","unstructured":"Nakamura N, Nakamine H, Tamaru J et al (2002) The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-myc rearrangement. Mod Pathol 15(7):771\u2013776. https:\/\/doi.org\/10.1097\/01.MP.0000019577.73786.64","journal-title":"Mod Pathol"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00728-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:05:18Z","timestamp":1787879118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00728-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00728-z","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, the Baylor College of Medicine Institutional Review Board does not require approval.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, informed consent is not required.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, consent for publication is not required.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}